Astera Labs, Inc.
ALAB
$58.96
$0.1750.30%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
---|---|---|---|---|---|
Revenue | 179.32% | 206.23% | 619.03% | 269.44% | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | 179.32% | 206.23% | 619.03% | 269.44% | |
Cost of Revenue | 218.98% | 185.72% | 655.71% | 9.94% | |
Gross Profit | 167.64% | 212.67% | 609.25% | 1,086.47% | |
SG&A Expenses | 361.60% | 387.67% | 438.48% | 909.46% | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 239.69% | 213.54% | 257.57% | 305.09% | |
Operating Income | -98.40% | -349.97% | -38.23% | -338.35% | |
Income Before Tax | 0.07% | 896.84% | 12.30% | -363.98% | |
Income Tax Expenses | -285.87% | 234.69% | -265.66% | 10,129.27% | |
Earnings from Continuing Operations | 72.52% | -143.05% | 62.28% | -432.80% | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | 72.52% | -143.05% | 62.28% | -432.80% | |
EBIT | -98.40% | -349.97% | -38.23% | -338.35% | |
EBITDA | -88.31% | -436.82% | -37.33% | -343.47% | |
EPS Basic | -58.30% | 41.97% | 91.12% | -263.36% | |
Normalized Basic EPS | -75.84% | 290.48% | 79.34% | -216.47% | |
EPS Diluted | -62.45% | 41.97% | 91.12% | -263.36% | |
Normalized Diluted EPS | -78.21% | 290.48% | 79.34% | -216.47% | |
Average Basic Shares Outstanding | 313.77% | 318.55% | 324.42% | 46.63% | |
Average Diluted Shares Outstanding | 359.49% | 318.55% | 324.42% | 46.63% | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |